
Validea's Growth Investor model, based on Martin Zweig's strategy, rates Intuitive Surgical (ISRG) at 77%, falling just below the 80% threshold that typically indicates strategic interest. The analysis, which targets growth stocks with accelerating earnings and sales, reasonable valuations, and low debt, found ISRG passes on revenue/sales growth and debt/equity, but fails on its P/E ratio and earnings persistence. As a large-cap medical equipment stock, ISRG demonstrates some alignment with the Zweig growth criteria but also exhibits mixed fundamental signals that prevent a higher rating under this specific guru model.
Based on Validea's implementation of the Martin Zweig growth strategy, Intuitive Surgical, Inc. (ISRG) scores 77%, placing it just below the 80% threshold that typically signals strategic interest. The analysis reveals a company with strong, accelerating near-term growth dynamics, as evidenced by its passing marks on current quarter earnings, sales growth rate, and EPS growth that outpaces both the prior three quarters and its historical rate. Furthermore, ISRG meets the model's criteria for a low total debt/equity ratio and favorable insider transaction patterns. However, these positive factors are counterbalanced by significant fundamental concerns. The model registers a 'FAIL' on the P/E ratio, indicating that the stock's valuation may be too high to meet the strategy's 'reasonable valuation' requirement. More critically, it also fails on 'Earnings Persistence' and the earnings growth rate over the 'past several quarters', suggesting the recent acceleration may not be sustainable and follows a period of inconsistent performance.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment